Almanack Investment Partners’s Tenaya Therapeutics TNYA Stock Holding History

Almanack Investment Partners’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	+168,200	New	+$128K	0.02%	309

Other funds holding TNYA

Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Integrity Wealth Solutions Denver, Colorado $271M AUM 21.83% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return

Parkwoods Wealth Partners Syracuse, New York $622M AUM 24.36% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Almanack Investment Partners's TNYA Position: Q2 2026 in Review

Almanack Investment Partners opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 168,200 shares worth $124K. The stake represents 0.02% of the portfolio and ranks #309 among its holdings.

25 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Almanack Investment Partners held 168,200 shares of Tenaya Therapeutics worth $124K as of Q2 2026.
Tenaya Therapeutics was a new Almanack Investment Partners position in Q2 2026.
Tenaya Therapeutics made up 0.02% of Almanack Investment Partners's portfolio in Q2 2026, its #309 holding.
25 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.